ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

NCI To Send Eight To AIDS Conference, Few Will Attend Cancer Meetings

February 28, 1992

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978

Letters to The Editors: Donald Coffey Finds Sensationalism Hurts

June 6, 1997

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984